Establishment of a cervical cancer model via inoculating SiHa cells into humanized severe combined immunodeficient mice

European Journal of Gynaecological Oncology

Volumn 27, Issue 6, 2006, Pages 566-572

  Ye, F ^a   Chen, H ^a   Liang, Z ^a   Lu, W ^a   Cheng, Q ^a   Xie, X ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Animal model; Cercival carcinoma; HPV; SCID mice

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOGLOBULIN G;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER SURVIVAL; CARCINOGENESIS; COMBINED IMMUNODEFICIENCY; CYTOTOXICITY; EXPERIMENTAL MODEL; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; SPLEEN CELL; SPLEEN WEIGHT; T LYMPHOCYTE; TUMOR GROWTH; UTERINE CERVIX CANCER;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LYMPHOCYTE TRANSFUSION; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PAPILLOMAVIRUS INFECTIONS; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS;

EID: 33846466011     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Moniz M., Ling M., Hung C.F., Wy T.C.: "HPV DNA vaccines". Front Biosci, 2003, 8, 55.
2. Vizcaino A.P., Moreno V., Bosch F.X., Munoz N., Barros-Dios X.M., Borras J. et al.: "International trends in incidence of cervical cancer: II. Squamous-cell carcinoma". Int. J. Cancer, 2000, 86, 429.
3. Walsh J.M.: "Cervical cancer: developments in screening and evaluation of the abnormal Pap smear". West J. Med., 1998, 169, 304.
4. Eiben G.L., da Silva D.M., Fausch S.C., Le Poole I.C., Nishimura M.I., Kast W.M.: "Cervical cancer vaccines: recent advances in HPV research". Viral Immunol, 2003, 16, 111.
5. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J. et al.: "Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group". J. Natl. Cancer Inst., 1995, 87, 796,
6. Stoler M.H.: "Human papillomaviruses and cevical neoplasia: a model for carcinogenesis". Int. J. Gynecol. Pathol., 2000, 19, 16.
7. Porreco R., Penn I., Droegenueller W., Greer B., Makowski E.: "Gynecologic malignancies in immunosuppressed organo homograft recipients". Obstet. Gynecol., 1975, 45, 359.
8. Wright T.C. Jr, Ellerbrock T.V., Chiasson M.A., Van Devanter N., Sun X.W.: "Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study". Obstet. Gynecol., 1994, 84, 591.
9. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright T.C. Jr.: "Human papillomavirus infection in women infected with the human immunodeficiency virus". N. Engl. J. Med., 1977, 337, 1343.
10. Su P.F., Wu F.Y.-H.: "Differential suppression of the tumorigenicity of Heal and SiHa cells by adeno-associated virus". Br. J. Cancer, 1996, 73, 1533.
11. Gallo D., Ferlini C., Distefano M., Cantelmo F., Gaggini C., Fattorossi A. et al. : "Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer". Cancer Chemother. Pharmacol., 2000, 45, 127.
12. Williams S.S., Alosco T.R., Croy B.A., Bankert R.B.: "The study of human neoplastic disease in severe combined immunodeficient mice". Lab. Anim. Sci., 1993, 43, 139.
13. Bonnet D., Warren E.H., Greenberg P.D., Dick J.E., Riddel S.R.: "CD8 (+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute nyeloid leukemia stem cells". Proc. Natl. Acad. Sci. USA, 1999, 96, 8639.
14. Hu W.X., Zeng Z.J., Luo S.Q., Chen Q.: "Suicide gene theraphy of human breast cancer in SCID mice model by the regulation of Tet-On. Chin. Med. J. (Engl.), 2004, 117, 434.
15. Krepier C., Wahceck V., Strommer S., Hartmann G., Polterauer P., Wolff K. et al : "CpG oligonucleotides elicit antitumor responses in a human melanoma NOD/SCID xenotransplantation mode". J. Invest. Dermatol., 2004, 122, 387.
16. Mosier D.E., Gulizia R.J., Baird S.M., Wilson D.B.: "Transfer of a functional human immune system to mice with severe combined immunodeficiency". Nature, 1988, 335, 256.
17. Walker W., Gallagher G.: "The development of a noval immunotherapy model of human ovarian cancer in human PBL-severe combined immunodeficient (SCID) mice". Clin. Exp. Immunol., 1995, 101, 494.
18. Schumacher U., Adam E., Horny H.P., Dietl J.: "Transplantation of a human ovarian cystadenocarcinoma into severe combined immunodeficient (SCID) mice-formation of metastases without significant alteration of the tumour cell phenotype". Int. J. Exp. Pathol., 1996, 77, 219.
19. Walker W., Gallagher G.: "The in vivo production of specific human antibodies by vaccination of human-PBL-SCID mice". Immunology, 1994, 83, 163.
20. Williamson L.M., Warwick R.M.: "Transfusion-associated graft-versus-host disease and its prevention". Blood Rev., 1995, 9, 251.
21. Zhu H., Ye D., Chen H., Lu W., Xie X.: "Development of intraperitoneally transplantated human ovarian carcinoma model with immune reconstruction in severe combined immunodeficient mice". Zhonghua Yi Xue Za Zhi, 2002, 82, 630.
22. Murase N., Starzl T.E., Tanabe M., Fujisaki S., Miyazawa H., Ye Q. et al.: "Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats". Transplantation, 1995, 60, 158.